Takeda Pharmaceutical (TAK) vs Teva Pharmaceutical Industries (TEVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Teva Pharmaceutical Industries (TEVA) has outperformed Takeda Pharmaceutical (TAK) over the past year, gaining 95.2% versus a gain of 27.0%. Over five years, TEVA leads with a +304.8% price change compared with +30.3% for TAK. Takeda Pharmaceutical is the larger company by market cap ($58.68 billion vs $45.70 billion), about 1.3 times the size.
On valuation, Teva Pharmaceutical Industries trades at a lower forward P/E (12.7x vs 34.7x for Takeda Pharmaceutical). Takeda Pharmaceutical pays a dividend yielding 1088.73%, while Teva Pharmaceutical Industries does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TAK | TEVA |
|---|---|---|
| Share price | $18.37 | $39.18 |
| Market cap | $58.68B | $45.70B |
| 1-day change | +1.49% | +0.13% |
| YTD return | +17.83% | +25.54% |
| 1-year return | +27.04% | +95.22% |
| 5-year return | +30.28% | +304.75% |
| P/E ratio (TTM) | — | 65.30 |
| Forward P/E | 34.66 | 12.68 |
| EPS (TTM) | $-0.34 | $0.60 |
| Dividend yield | 1088.73% | 0.00% |
| Annual dividend | $200.00 | $0.00 |
| Revenue (latest FY) | — | $17.26B |
| Revenue growth (YoY) | — | +4.32% |
| Net income (latest FY) | — | $1.41B |
| Gross margin | — | 51.79% |
| Operating margin | — | 12.50% |
| Net margin | — | 8.17% |
| 52-week high | $19.10 | $40.79 |
| 52-week low | $12.99 | $18.83 |
| Distance from 52-week high | -3.82% | -3.95% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +19.54% | +15.62% |
| Average volume | 3.03M | 5.32M |
| Shares outstanding | 3.19B | 1.17B |
| Employees | 47,029 | 31,173 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TEVA has outperformed TAK by 68.2 percentage points over the past year.
- Takeda Pharmaceutical offers a meaningfully higher dividend yield (1088.73% vs 0.00%).
About Takeda Pharmaceutical
TAK stock →Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.
Healthcare · Drug Manufacturers - Specialty & Generic · 47,029 employees
About Teva Pharmaceutical Industries
TEVA stock →Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products.
Healthcare · Drug Manufacturers - Specialty & Generic · 31,173 employees
TAK vs TEVA FAQ
Which is bigger, Takeda Pharmaceutical or Teva Pharmaceutical Industries?
Takeda Pharmaceutical (TAK) is larger, with a market capitalization of $58.68B compared with $45.70B for Teva Pharmaceutical Industries (TEVA).
Which stock has performed better over the past year, TAK or TEVA?
TEVA returned +95.22% over the past 12 months, compared with +27.04% for TAK (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Takeda Pharmaceutical or Teva Pharmaceutical Industries?
Takeda Pharmaceutical pays a dividend yielding 1088.73%, while Teva Pharmaceutical Industries does not currently pay a regular dividend.
Are Takeda Pharmaceutical and Teva Pharmaceutical Industries in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.